TEES

Maitland receives Texas A&M System Technology Commercialization 2015 Innovation Award

May 13, 2015
| By: Ryan Garcia

photo of Duncan Maitland   Duncan Maitland, the Stewart & Stevenson Professor in the Department of Biomedical Engineering at Texas A&M University, has been named recipient of the 2015 Innovation Award, presented by Texas A&M System Technology Commercialization (TTC).

In addition to his research and teaching duties, Maitland is the Texas A&M Engineering Experiment Station’s (TEES) assistant agency director for commercialization and entrepreneurship.

The award recognizes individuals whose research and accomplishments exemplify the spirit of innovation within The Texas A&M University System. Maitland received the award during the annual Patent and Innovations Awards luncheon, held this month at the Annenberg Presidential Conference Center.

“Dr. Maitland was recognized with an Innovation Award because he not only is a great scientist, but he has taken the leap into entrepreneurship by founding Shape Memory Therapeutics to commercialize his innovations,” noted Brett L. Cornwell, associate vice chancellor for commercialization for the TTC. “He has also applied his passion for commercialization to his work in TEES, assisting researchers with their commercial ideas.”

Maitland’s research focuses on novel treatments of cardiovascular disease with a focus on stroke. His research projects include endovascular interventional devices, microactuators, optical therapeutic devices and basic device-body interactions/physics including computational and experimental techniques.

He earned a bachelor’s degree in electrical engineering from Cleveland State University, a master’s in physics from Cleveland State and his Ph.D. in biomedical engineering from Northwestern University.

 It is the mission of TTC to encourage broad practical application of system research for public benefit; to encourage and assist those associated with the system in the protection, licensing and commercialization of their discoveries; to ensure the equitable distribution of royalties and other monetary benefits resulting from the commercial application of intellectual property; and to see that commercialization activities benefit the research, education and outreach missions of the system into the future.

Have a question? Not finding what you're looking for? Let us get you in touch with the right person.

Fill out the form below or give us a call at (979) 458-1648 to reach us.

Contact